𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Recombinant Protein- and Synthetic Peptide-Based Immunoblot Test for Diagnosis of Neurocysticercosis

✍ Scribed by Noh, J.; Rodriguez, S.; Lee, Y.-M.; Handali, S.; Gonzalez, A. E.; Gilman, R. H.; Tsang, V. C. W.; Garcia, H. H.; Wilkins, P. P.

Book ID
125851042
Publisher
American Society for Microbiology
Year
2014
Tongue
English
Weight
488 KB
Volume
52
Category
Article
ISSN
0095-1137

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Recombinant protein-based ELISA and immu
Recombinant protein-based ELISA and immuno-cytochemical assay for the diagnosis of SARS
✍ Alessandra Carattoli; Paola Di Bonito; Felicia Grasso; Colomba Giorgi; Francesco πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 168 KB

## Abstract A new Coronavirus (SARS‐CoV) is the aetiological agent of the severe acute respiratory syndrome (SARS). Because of the critical role played by serological assays for SARS diagnosis, an in‐house ELISA based on SARS‐CoV recombinant antigens was developed. The SARS‐CoV nucleocapsid protein

Use of a synthetic peptide-based elisa f
Use of a synthetic peptide-based elisa for the diagnosis of infectious mononucleosis and other diseases
✍ John E. Geltosky; Richard S. Smith; Alice Whalley; Gary Rhodes πŸ“‚ Article πŸ“… 1987 πŸ› John Wiley and Sons 🌐 English βš– 890 KB

A simple enzyme immunoassay has been developed based on measuring antibodies to synthetic peptides corresponding to sequences in the Epstein-Barr nuclear antigen (EBNA). This assay, which is repro-ducible, quantitative, and simple to perform and interpret, can be an effective tool to aid in the diag